Edison Group: Analys av Xintela

Edison Group: Analys av Xintela

Xintela, backed by its integrin biomarker technology platform XINMARK, is a potential disrupter in the regenerative stem cell and oncology areas.

Dela:

Facebook
X
LinkedIn